Insulin Glargine Market Size to Reach USD 2,200 Million by 2031 Driven by Rising Diabetes Prevalence and Increasing Demand for Long-acting Insulin Therapies
Market Overview The global Insulin Glargine Market is witnessing significant growth due to the rising prevalence of diabetes and increasing demand for effective long-acting insulin therapies worldwide. Insulin glargine is widely used for the treatment of type 1 and type 2 diabetes as it helps maintain stable blood glucose levels over an extended duration, improving patient convenience and...
0 Commenti 0 Condivisioni 104 Visualizzazioni